La toxicidad financiera del cáncer, un efecto adverso silenciado en los sistemas sanitarios públicos
Navas Huerga, Rocío.
Metas enferm
; 26(2): 3-6, Mar. 2023.
Artículo en Español | IBECS (España) | ID: ibc-216543
Documentos relacionados
[Development of a set of nursing-sensitive indicators for Swiss practice].
OB Nest randomized controlled trial: a cost comparison of reduced visit compared to traditional prenatal care.
Measuring Nursing Care Value.
Challenging government health rhetoric.
Socio-demographic analysis of free-lance nurses in a non-institutional employment regimen.
Increased care demand and medical costs after falls in nursing homes: A Delphi study.
How public health services pay for radiotherapy in Europe: an ESTRO-HERO analysis of reimbursement.
Best Buy in Public Health or Luxury Expense?: The Cost-effectiveness of a Pediatric Operating Room in Uganda From the Societal Perspective.
Hospital Capital Assets, Community Health, and the Utilization and Cost of Inpatient Care: A Population-Based Study of US Counties.
The economic benefits of increased levels of nursing care in the hospital setting.